225 related articles for article (PubMed ID: 7801784)
21. Effects of CI-930, a novel phosphodiesterase III inhibitor, on platelet aggregation and arachidonic acid metabolism.
Chen XS; Zeng HW; Jiang YY; Wan WQ; Long K
Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):338-43. PubMed ID: 1966575
[TBL] [Abstract][Full Text] [Related]
22. Tetrandrine differentially inhibits aggregation and ATP-release of rat platelets.
Chen YY; Kwan CY; Hui SC
Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):105-8. PubMed ID: 9772654
[TBL] [Abstract][Full Text] [Related]
23. Effects of protopine on blood platelet aggregation. II. Effect on metabolic system of adenosine 3',5'-cyclic monophosphate in platelets.
Shiomoto H; Matsuda H; Kubo M
Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2320-2. PubMed ID: 2177684
[TBL] [Abstract][Full Text] [Related]
24. Effects of glaucocalyxin A on aggregation and cAMP levels of rabbit platelets in vitro.
Zhang B; Long K
Zhongguo Yao Li Xue Bao; 1993 Jul; 14(4):347-50. PubMed ID: 8249632
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of tetrahydroberberine on platelet aggregation and thrombosis.
Xuan B; Wang W; Li DX
Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):133-5. PubMed ID: 8010106
[TBL] [Abstract][Full Text] [Related]
26. [Effects of 6-(alpha alpha-diphenylacetylpiperazinyl) phenyl-5-methyl-4,5-dihydro-3 (2H)-pyridazinone on rabbit platelet aggregation and TXB2, cAMP production].
Zeng GQ; Wang XS; Sun DX; Lin AY; Ji Y; Chu JX; Rui YC
Yao Xue Xue Bao; 1993; 28(4):256-9. PubMed ID: 8213167
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets.
Li BY; Bai Y; Li WH
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):58-62. PubMed ID: 10375761
[TBL] [Abstract][Full Text] [Related]
28. [Effect of dauricine on rat and human platelet aggregation and metabolism of arachidonic acid in washed rat platelets].
Tong L; Yue TL
Yao Xue Xue Bao; 1989; 24(2):85-8. PubMed ID: 2801142
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of platelet aggregation by chlorogenic acid via cAMP and cGMP-dependent manner.
Cho HJ; Kang HJ; Kim YJ; Lee DH; Kwon HW; Kim YY; Park HJ
Blood Coagul Fibrinolysis; 2012 Oct; 23(7):629-35. PubMed ID: 22885765
[TBL] [Abstract][Full Text] [Related]
30. Antiplatelet activity of beta-carboline alkaloids from Perganum harmala: a possible mechanism through inhibiting PLCgamma2 phosphorylation.
Im JH; Jin YR; Lee JJ; Yu JY; Han XH; Im SH; Hong JT; Yoo HS; Pyo MY; Yun YP
Vascul Pharmacol; 2009; 50(5-6):147-52. PubMed ID: 19073282
[TBL] [Abstract][Full Text] [Related]
31. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
[TBL] [Abstract][Full Text] [Related]
33. Effect of isoquinoline alkaloids of different structural types on antiplatelet aggregation in vitro.
Chia YC; Chang FR; Wu CC; Teng CM; Chen KS; Wu YC
Planta Med; 2006 Oct; 72(13):1238-41. PubMed ID: 16981134
[TBL] [Abstract][Full Text] [Related]
34. MCI-9042, a new antiplatelet agent is a selective S2-serotonergic receptor antagonist.
Hara H; Osakabe M; Kitajima A; Tamao Y; Kikumoto R
Thromb Haemost; 1991 Apr; 65(4):415-20. PubMed ID: 2057925
[TBL] [Abstract][Full Text] [Related]
35. Effects of methylprednisolone and hydrocortisone on aggregation of rabbit platelets induced by arachidonic acid and other aggregating substances.
Glass F; Lippton H; Kadowitz PJ
Thromb Haemost; 1981 Dec; 46(4):676-9. PubMed ID: 6800048
[TBL] [Abstract][Full Text] [Related]
36. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.
Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL
Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010
[TBL] [Abstract][Full Text] [Related]
37. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity.
Jin YR; Im JH; Park ES; Cho MR; Han XH; Lee JJ; Lim Y; Kim TJ; Yun YP
J Cardiovasc Pharmacol; 2008 Jan; 51(1):45-54. PubMed ID: 18209568
[TBL] [Abstract][Full Text] [Related]
38. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
[TBL] [Abstract][Full Text] [Related]
39. [Effects of ketotifen on rabbit platelet aggregation and platelet activating factor formation from rat neutrophils].
Wang XD; Bian RL
Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):524-7. PubMed ID: 2130617
[TBL] [Abstract][Full Text] [Related]
40. Influence of thiofedrine on platelet aggregation, intraplatelet cyclic cAMP and malondialdehyde in rats.
Qu YZ; Li XX
Methods Find Exp Clin Pharmacol; 1994 May; 16(4):253-6. PubMed ID: 8051984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
